IHAM
AXSM icon

Integral Health Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Integral Health Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.4M Buy
300,000
+265,000
+757% +$57.5M 2.9% 7
2026
Q1 		$5.92M Buy
+35,000
New +$6.05M 0.28% 74
2024
Q2 		– Sell
-30,000
Closed -$2.39M – 81
2024
Q1 		$2.39M Buy
+30,000
New +$2.52M 0.22% 79

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integral Health Asset Management's AXSM Position: Q2 2026 in Review

Integral Health Asset Management increased its Axsome Therapeutics (AXSM) stake by 757% in Q2 2026, buying an estimated $57.5M and bringing the position to 300,000 shares worth $73.4M. The position accounts for 2.9% of the portfolio, ranked #7.

Integral Health Asset Management first reported a position in AXSM in Q1 2024 and has held it in 3 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Integral Health Asset Management held 300,000 shares of Axsome Therapeutics worth $73.4M as of Q2 2026.
  • Integral Health Asset Management bought 265,000 Axsome Therapeutics shares in Q2 2026, an estimated $57.5M.
  • Axsome Therapeutics made up 2.9% of Integral Health Asset Management's portfolio in Q2 2026, its #7 holding.
  • Integral Health Asset Management first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.